Scalp absorption study of DA-020 in healthy women
Treatments studied
Part of Cancer clinical trials.
This early-phase study tests how a new scalp product (DA-020) is absorbed through the skin in healthy women. It aims to see how the body processes the medication, which could later help treat conditions like hair loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy woman between 18 and 55 years old
- Have a body mass index (BMI) between 18 and 30
- Have a skin type (Fitzpatrick I–IV) that allows standard absorption testing
- Have a scalp that's free from irritation, wounds, or significant hair loss
- Be willing to avoid using other scalp products during the study
- Not have heart disease, high blood pressure, or irregular heartbeat
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
This study tests a product called DA-007 applied to the scalp to help prevent hair loss caused by chemotherapy. It is for people with early-stage breast cancer who are about to start certain types of chemotherapy.
This study tests how a topical phenylephrine solution is absorbed through the scalp in healthy women. It aims to understand the drug's safety and how the body processes it.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
This study tests a new scalp product called DA-001 to see if it reduces hair shedding and helps hair grow back in people with telogen effluvium. It's a clinical trial that compares the treatment to a placebo (a product without the active ingredient) to find out if it works.
Hear when a new Chemotherapy Induced Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.